Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19318496

Clin. Cancer Res. 2009 Apr 15 15 8 2913-9

Download in:

View as

Triples

General Info

PMID
19318496